Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Summary of Significant Accounting Policies (Details Textual)

v3.21.2
Note 3 - Summary of Significant Accounting Policies (Details Textual) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Research and Development Expense [Member]    
Patent Expense $ 89,000 $ 82,000